Drug Delivery Technologies Market By Application (Oral, Pulmonary, Transdermal, Injectable, Nasal, Implantable & Others) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2024

14 Apr 2016 Format PDF icon PPT icon XLS icon Request Sample

Various drug delivery technologies assist in adjusting dosage release with best possible safety and efficacy. Drug delivery technologies simplify the challenge of patient compliance, facilitate precision in dosage and reduce side effects. For the purpose of this study, the global drug delivery devices market is studied in terms of mode of administration and geography.

In terms of mode of administration, the global drug delivery devices market is categorized into oral, pulmonary, injectable, nasal, implantable, and ocular, buccal etc. segments. Each of these segments is studied for their current market status and future prospect. Market size and forecast (in terms of USD Bn) for the period 2014 to 2023, with compounded annual growth rate (CAGR %) for 2016 to 2023.

Geographically, North America, Europe, Asia-Pacific, Latin America and Middle East and Africa together form the global drug delivery technologies market. Similar to segmentation by mode of administration the geographic markets are also studied in terms of their current and future market value. Market revenue and forecast for the period 2014 to 2023 along with the respective CAGRs for 2016 to 2023 are provided in this report for each respective regional market and certain key national markets. 

Apart from market size and forecast this report on global drug delivery market, this report also includes qualitative information sets such as market dynamics information: drivers, challenges, and future prospects. Fractal map analysis for analyzing the overall market competition and attractive investment proposition tools are also included in the study. This report concludes with company profiles section that highlights key information of the major market players operating in the global drug delivery technologies market.

Oral, injectable, implantable, pulmonary, transdermal, nasal, and ocular, buccal and others are the prime segments of drug delivery technologies market. Oral and injectable administrations are the oldest modes of drug delivery and together take over 55% market share in 2015. The two modes represent the widest range of drugs in the pharmaceuticals market and are observed to be the most affordable methods accepted worldwide.  

Major factors determining the growth of this market are the growing incidence of chronic diseases, rapid innovation, technological development and the ongoing growth of biologics market. Additionally, the demand for transdermal delivery methods is estimated to flourish during the forecast period. Convenience in use, ease of self administration, accuracy of delivering right dosage at right location, and painless drug delivery are the prime factors contributing the growth of transdermal drug delivery segment.

Implantable drug delivery segment will undergo the fastest growth during the forecast period. Specific site drug administration, reduction in burden of patient compliance and advantage of sustained drug release are the prime factors that drive the growth of this segment.

In terms of geographic distribution, North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America cumulatively make the global drug delivery technologies market. 

North America and Europe together capture over 60% of the global drug delivery technologies market revenue. Adoption of novel non-oral drug administration modes such as transdermal, implantable and pulmonary drug delivery is rapid and on a large scale in North America. Products such as dry powder inhalers, pen injectors for seasonal allergies, orodispersable tablets and other control release products are in high demand in the developed markets. Use of implantable devices such as drug eluting stents is increasingly used in treating chronic illnesses and for contraception.

Moreover, major players in the developing drug delivery technologies are primarily domiciled in Europe and U.S., thus giving the regions an early bird advantage in terms of rapid product adoption. High level of awareness among both care givers and patients also significantly contributes to the above trend. Intense competition among drug manufacturers and growing trend of outsourcing of manufacturing process has made this market fragmented, with numerous players coming up with newer drug delivery formulations technologies. This report also studies the global drug delivery technologies market based on major national and regional level. 

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Drug Delivery Technologies market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Drug Delivery Technologies market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Mode of Administration
  • Oral
  • Pulmonary
  • Transdermal
  • Injectable
  • Nasal
  • Implantable
  • Others

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Drug Delivery Technologies market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Drug Delivery Technologies market?
  • Which is the largest regional market for Drug Delivery Technologies market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Drug Delivery Technologies market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Drug Delivery Technologies market worldwide?
Choose Licence Type
Why Acute
View Other Reports